{ "OCM™ for Diabetic Foot Ulcers", "This study is looking at two ways to treat diabetic foot ulcers (DFUs), which are sores on the feet that can affect people with diabetes. One group will receive the usual care (Standard of Care or SOC), and the other group will receive SOC plus a product called Omeza® Complete Matrix (OCM™). The goal is to see if adding OCM™ helps these ulcers heal completely. You might be able to join if you are 18 or older, have Type 1 or Type 2 diabetes, and have a diabetic foot ulcer that has been present for at least 4 weeks but less than 12 months. The study will measure how many people achieve complete wound closure within 1 to 12 weeks.", "design": "This is an open-label study, meaning both you and the researchers will know which treatment you are receiving. You will be randomly assigned to one of two groups, with a planned enrollment of 130 participants.", "commitments": "If you are in the SOC group and your wound hasn't closed after about 84 days, you may be able to switch to the OCM™ treatment, which involves weekly applications for up to 12 visits.", "compensation": "Not stated in the trial record.", "follow_up": "The study will track complete wound closure for up to 12 weeks.", }

Study design

Not specified.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.